The Journal of Immunology, Vol 157, Issue 11 4908-4917, Copyright © 1996 by American Association of Immunologists

ARTICLES

1alpha,25-Dihydroxyvitamin D3 modulates CD38 expression on human lymphocytes

JD Stoeckler, HA Stoeckler, N Kouttab and AL Maizel
Department of Pathology, Roger Williams Medical Center and Brown University, Providence, RI 02908, USA.

B cells from chronically stimulated tonsils displayed high initial mean CD38 levels that declined during in vitro culture, despite ligation of CD40 and/or the Ag receptor in the presence of IL-4. Exposure to 1alpha,25-dihydroxyvitamin D3 (1,25(OH)2D3) restored the initial CD38 expression on these stimulated cells and up-regulated the Ag on stimulated CD38-/low cells. 1,25(OH)2D3 enhanced CD38 expression by four- to sixfold on CD8- and CD8+ peripheral blood T cells following PHA activation. The EC50 values for induction were 2 to 3 nM. Although all-trans-retinoic acid also induced CD38 expression on stimulated B and T cells, it was less effective than 1,25(OH)2D3. B cell CD38 expression was augmented less by 1,25(OH)2D3 than by IFN-alpha and IFN- gamma. However, T cell CD38 expression was induced more strongly by 1,25(OH)2D3 than by IFN-alpha, and was unaffected by IFN-gamma. The CD38 density on activated 1,25(OH)2D3-treated CD38-/low B and peripheral T cells was proportional to cell size, indicating that hormonal induction depended upon entry into the cell cycle. While IFNs induced CD38 rapidly in stimulated T and B lymphocytes, 1,25(OH)2D3 exerted its effects only after initial 1- to 3-day delays, suggesting a requirement for nuclear 1,25(OH)2D3 receptor up-regulation. In HL-60 cells, which constitutively express the nuclear receptors, 1,25(OH)2D3 rapidly induced CD38 Ag and ectoenzyme activity. The CD38 density on freshly isolated unfractionated tonsillar B lymphocytes and on the activated 1,25(OH)2D3-treated cultured cells was nearly identical for cells within the same size range, indicating that in vitro hormonal exposure reconstituted in vivo CD38 expression levels.

This article has been cited by other articles:

				A.-K. Shirakawa, D. Nagakubo, K. Hieshima, T. Nakayama, Z. Jin, and O. Yoshie 1,25-Dihydroxyvitamin D3 Induces CCR10 Expression in Terminally Differentiating Human B Cells J. Immunol., March 1, 2008; 180(5): 2786 - 2795. [Abstract] [Full Text] [PDF]

				S. Chen, G. P. Sims, X. X. Chen, Y. Y. Gu, S. Chen, and P. E. Lipsky Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation J. Immunol., August 1, 2007; 179(3): 1634 - 1647. [Abstract] [Full Text] [PDF]

				T. Musso, S. Deaglio, L. Franco, L. Calosso, R. Badolato, G. Garbarino, U. Dianzani, and F. Malavasi CD38 expression and functional activities are up-regulated by IFN-{gamma} on human monocytes and monocytic cell lines J. Leukoc. Biol., April 1, 2001; 69(4): 605 - 612. [Abstract] [Full Text]

				D. Ford, C. Sheehan, C. Girasole, R. Priester, N. Kouttab, J. Tigges, T. C. King, A. Luciani, J. W. Morgan, and A. L. Maizel The Human B Cell Response to IL-13 Is Dependent on Cellular Phenotype as Well as Mode of Activation J. Immunol., September 15, 1999; 163(6): 3185 - 3193. [Abstract] [Full Text] [PDF]

				H. Kishimoto, S.-i. Hoshino, M. Ohori, K. Kontani, H. Nishina, M. Suzawa, S. Kato, and T. Katada Molecular Mechanism of Human CD38 Gene Expression by Retinoic Acid. IDENTIFICATION OF RETINOIC ACID RESPONSE ELEMENT IN THE FIRST INTRON J. Biol. Chem., June 19, 1998; 273(25): 15429 - 15434. [Abstract] [Full Text] [PDF]

				H. Ogata, D. Ford, N. Kouttab, T. C. King, N. Vita, A. Minty, J. Stoeckler, D. Morgan, C. Girasole, J. W. Morgan, et al. Regulation of Interleukin-13 Receptor Constituents on Mature Human B Lymphocytes J. Biol. Chem., April 17, 1998; 273(16): 9864 - 9871. [Abstract] [Full Text] [PDF]